Pharmaceutical Drug Targets and Diseases: Difference between revisions
David Canner (talk | contribs) No edit summary |
David Canner (talk | contribs) No edit summary |
||
| Line 9: | Line 9: | ||
***[[Acetylcholinesterase]] | ***[[Acetylcholinesterase]] | ||
***[[2ace|Acetylcholinesterase from Torpedo Californica]] | ***[[2ace|Acetylcholinesterase from Torpedo Californica]] | ||
***[[African Malaria Mosquito Acetylcholinesterase]] | |||
***[[SANDBOX138|Human APP Intracellular Domain Complex with Fe65-PTB2]] | ***[[SANDBOX138|Human APP Intracellular Domain Complex with Fe65-PTB2]] | ||
***[[Flexibility of aromatic residues in acetylcholinesterase|Aromatic Residue Flexibility in AChE]] | ***[[Flexibility of aromatic residues in acetylcholinesterase|Aromatic Residue Flexibility in AChE]] | ||